 Red cell membrane erythropoietin therapy hemodialysis hemodiafiltration study effect recombinant human erythropoietin r-HuEPO red cell behaviour patients undergoing hemodialysis HD hemodiafiltration HDF erythrocyte osmotic fragility EOF mechanical fragility EMF deformability ED r-HuEPO therapy patients conventional dialysis treatment cuprophan membrane subjects HDF polyacrylonitrile membrane Non-uremic non-anemic subjects controls Red cell membrane defects evident HD HDF r-HuEPO deformability groups controls great production red cells therapy